(Q46809704)

25 December 2017

title

Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole (English)

1 reference

25 December 2017

author name string

A E Goda

1

1 reference

25 December 2017

T Yoshida

2

1 reference

25 December 2017

M Horinaka

3

1 reference

25 December 2017

T Yasuda

4

1 reference

25 December 2017

T Shiraishi

5

1 reference

25 December 2017

M Wakada

6

1 reference

25 December 2017

T Sakai

7

1 reference

25 December 2017

language of work or name

English

0 references

publication date

14 January 2008

1 reference

25 December 2017

published in

Oncogene

1 reference

25 December 2017

volume

27

1 reference

25 December 2017

issue

24

1 reference

25 December 2017

page(s)

3435-3445

1 reference

25 December 2017

Validating survivin as a cancer therapeutic target

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Caspase-3 is a component of Fas death-inducing signaling complex in lipid rafts and its activity is required for complete caspase-8 activation during Fas-mediated cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Targeting TRAIL agonistic receptors for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

The type III phosphodiesterase inhibitor milrinone and type V PDE inhibitor dipyridamole individually and synergistically reduce elevated pulmonary vascular resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Dipyridamole inhibits PDGF-stimulated human peritoneal mesothelial cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Control of apoptosis and mitotic spindle checkpoint by survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Dipyridamole increases the cytotoxicity of cisplatin in human larynx cancer cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

15-Deoxy-Δ12,14-prostaglandin J2 induces apoptosis through activation of the CHOP gene in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Cyclic 3',5'-adenosine monophosphate in human blood platelets. IV. Regulatory role of cyclic amp in platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Selection of Drugs to Test the Specificity of the Tg.AC Assay by Screening for Induction of the gadd153 Promoter in Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Promoter structure and transcription initiation sites of the human death receptor 5/TRAIL-R2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Halocynthiaxanthin and peridinin sensitize colon cancer cell lines to tumor necrosis factor-related apoptosis-inducing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

Enhancement of methotrexate cytotoxicity towards the MDA.MB.436 human breast cancer cell line by dipyridamole. The role of methotrexate polyglutamates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

7 January 2021

inferred from DOI database lookup

Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

7 January 2021

inferred from DOI database lookup

Mechanism of dipyridamole's action in inhibition of venous and arterial smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211008

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/SJ.ONC.1211008

1 reference

25 December 2017

Dimensions Publication ID

1045410141

0 references

Fatcat ID

release_fgreye22mzem7pfzds5er66eou

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fgreye22mzem7pfzds5er66eou

24 November 2022

mapped directly with Wikidata item

1 reference

25 December 2017